Genentech Awards $344K Research Contract to CMU
Trusted by teams at
Description
CMU was awarded a $344,668 contract from Genentech, Inc. to study crovalimab's pharmacodynamics in preventing vaso-occlusive episodes.
Contract Details
Contract Amount
$344,668.00
Vendor
GENENTECH INC
Agency
Central Michigan University, MI
Contract Type
CONTRACT
Document Date
September 28, 2023
Contract Term
2/20/2023 – 2/19/2025
Renewal Date
2025-02-19
Renewal Info
Covers a two-year period; no renewal information included.
More from GENENTECH INC
More from Central Michigan University
Central Michigan University Board of Trustees Meeting Agenda Packet February 2026
Central Michigan University Board of Trustees Meeting Agenda Packet February 2026
Central Michigan University Board of Trustees Meeting Agenda Packet February 2026
Central Michigan University Board of Trustees Meeting Agenda Packet February 2026
Central Michigan University Board of Trustees Meeting Agenda February 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.